Company hires for executive jobs in Boston
Posted on September 18, 2011
Boston Scientific said this week it has secured a key hire for executive jobs in Boston.
Boston Scientific named Michael Mahoney, 46, as President of the Company, effective October 17, 2011. Mahoney, Worldwide Chairman of the Medical Device and Diagnostics Group for Johnson & Johnson, is expected to become Chief Executive Officer (CEO) of Boston Scientific on November 1, 2012.
The transition period is being implemented to accommodate Mahoney’s post-employment obligations to Johnson & Johnson, which both Boston Scientific and Johnson & Johnson have agreed is appropriate. Ray Elliott, who announced last May that he would step down as President and CEO, will do so on October 17, 2011. At that time, Hank Kucheman, currently the Executive Vice President and Group President of the Cardiology, Rhythm and Vascular (CRV) Group, Boston Scientific’s largest business, will be promoted to serve as interim CEO until Mahoney assumes the role.
As President, Mahoney will report to Kucheman. In connection with his promotion to CEO, Kucheman will be appointed to the Company’s Board of Directors. Elliott will be available to assist Kucheman and Mahoney through the end of the year, at which time he will retire, and remain active on the Company’s Board of Directors.
“Mike is a dynamic, seasoned leader and we enthusiastically welcome him into the Boston Scientific family,” stated Pete Nicholas, Chairman of the Board and Co-Founder, Boston Scientific. “He is intensely passionate about innovation and people, and creates and encourages a team environment that results in superior performance. This, combined with Mike’s significant international experience made him the best choice for this critical role,” continued Nicholas.
As President, Mahoney’s initial responsibilities will focus on the oversight of Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary), as well as numerous corporate functions. On August 1, 2012, Mahoney will assume responsibility for Neuromodulation.
“I have great respect for Boston Scientific and its position as a market-leading, global Fortune 500 healthcare company,” stated Mahoney. “My experiences leading complex businesses, developing international markets and driving operational excellence for other world-class companies will serve me well in my new role. I am making a long-term commitment to continue Boston Scientific’s focus on innovation and delivering improved patient care while revitalizing the Company’s sustainable growth through the continued execution of its POWER strategy.”
Boston Scientific isn’t the only company hiring in the New England/New York area. Jackson Hewitt said this week it is hiring dozens for financial jobs in Long Island.